Illustration: Aïda Amer/Axios

The White House — despite its infinite access to the best resources available — continues to respond to its own coronavirus outbreak about as recklessly as possible.

Why it matters: This botched response has jeopardized the health of the president and his staff, and it has set a very poor example in a country that's already done a terrible job handling the virus.

Driving the news: President Trump left Walter Reed yesterday to return to the White House, but medical officials have not said he's past the point of being contagious.

  • This was about 24 hours after Trump left his hospital bed – and isolation — to drive around in a car to wave at his supporters, putting the Secret Service agents in the car with him at risk.
  • White House Press Secretary Kayleigh McEnany became the latest official to test positive for the virus yesterday — a day after she had gaggled maskless with reporters.
  • Vice President Mike Pence, who has been around numerous officials who have since tested positive for the virus, is still traveling on the campaign trail. Pence tested negative for the virus yesterday morning.

The White House is doing only minimal contact tracing, and has not sought help from the Centers for Disease Control and Prevention, per the NYT.

  • It has decided not to trace the contacts of attendees at last weekend’s Rose Garden event celebrating the nomination of Amy Coney Barrett to the Supreme Court. At least eight people who attended that event have since tested positive.
  • It’s opting instead to only notify Trump’s contacts in the two days before his diagnosis — an extensive list.

What he’s saying: “Don’t be afraid of Covid. Don’t let it dominate your life. We have developed, under the Trump Administration, some really great drugs & knowledge. I feel better than I did 20 years ago!” Trump tweeted yesterday afternoon.

What we're watching: White House residence staffers — many of whom are people of color or elderly — are already bearing the burden of this sloppiness, and may continue to, as the Washington Post points out.

The bottom line: Negligence within the White House led to the leader of the free world being hospitalized with a deadly virus.

  • This same negligence has exposed hundreds of people to the disease, who are doubtlessly exposing hundreds more people — within the White House complex, in the day care centers and gyms of Washington, D.C., and in states including New Jersey and Minnesota, where the president traveled before he was diagnosed.
  • Incompetence and recklessness have plagued America’s coronavirus response since the beginning of the pandemic. And the recklessness starts at the top.

Go deeper

Caitlin Owens, author of Vitals
19 hours ago - Health

Many U.S. coronavirus deaths were avoidable

Data: National Center for Disaster Preparedness; Chart: Sara Wise/Axios

If the U.S. death rate had matched that of other wealthy countries, between about 55,000 and 215,000 Americans would still be alive, according to a scathing new analysis by Columbia University's National Center for Disaster Preparedness.

Why it matters: These countries have taken a significantly different approach to the virus than the U.S., providing yet another example that things didn't have to be this way.

How the coronavirus pandemic could end

Illustration: Sarah Grillo/Axios

It's still the early days of the coronavirus pandemic, but history, biology and the knowledge gained from our first nine months with COVID-19 point to how the pandemic might end.

The big picture: Pandemics don't last forever. But when they end, it usually isn't because a virus disappears or is eliminated. Instead, they can settle into a population, becoming a constant background presence that occasionally flares up in local outbreaks.

10 hours ago - Health

FDA approves Gilead's remdesivir as a coronavirus treatment

A production line of Remdesivir. Photo: Fadel Dawood/picture alliance via Getty Images

Gilead Sciences on Thursday received approval from the Food and Drug Administration for remdesivir, an antiviral treatment that has shown modest results against treating COVID-19.

Why it matters: It's the first and only fully FDA-approved drug in the U.S. for treating the coronavirus.

Get Axios AM in your inbox

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Subscription failed
Thank you for subscribing!